Sign In
11 Jun 2012 08:32
11 June 2012
Regenersis plc
("Regenersis" or the "Company")
Director/PDMR Shareholding
Regenersis plc, a strategic outsourcing partner to many of the world's leading consumer technology companies, received notification on 7 June 2012 of the following director dealing in the ordinary shares of 2 pence each in the Company ("Shares").
On 7 June 2012, Dauphin Capital LP acquired 75,000 Shares. The purchase price of these shares was 93.5 pence per Share.
Matthew Peacock, Chairman of Regenersis, as a partner in Hanover Investors Management LLP, is connected to Dauphin Capital LP. The combined resultant holding of Hanover Investors Management LLP and its connected parties is 10,213,351 ordinary shares equating to 22.79 per cent. of the issued share capital of the Company.
Enquiries:
Regenersis plc | +44 (0) 20 7766 8400 |
Jog Dhody | |
Arden Partners plc (Nomad and Joint Broker) | +44 (0) 121 423 8900 |
Steve Douglas | |
Panmure Gordon (UK) Limited (Joint Broker) | +44 (0) 20 7459 3600 |
Dominic Morley / Brett Jacobs | |
FTI Consulting | +44 (0) 20 7831 3113 |
Matt Dixon / Charles Palmer / Jon Snowball |
Ends
Follow the stocks
